VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹627 Cr | ₹601 Cr | ₹579 Cr | ₹556 Cr | ₹644 Cr |
What is the latest Total Liabilities ratio of VENUS REMEDIES ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹627 Cr |
Mar2023 | ₹601 Cr |
Mar2022 | ₹579 Cr |
Mar2021 | ₹556 Cr |
Mar2020 | ₹644 Cr |
How is Total Liabilities of VENUS REMEDIES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹627 Cr | 4.28 | |
Mar2023 | ₹601 Cr | 3.79 | |
Mar2022 | ₹579 Cr | 4.19 | |
Mar2021 | ₹556 Cr | -13.66 | |
Mar2020 | ₹644 Cr | - |
Compare Total Liabilities of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹424.0 Cr | 6.5% | 2.1% | -21.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹433,848.0 Cr | 2.7% | -2.4% | 49.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹165,923.0 Cr | 2.9% | 6.2% | 64.2% | Stock Analytics | |
CIPLA | ₹121,796.0 Cr | 1% | 6.4% | 28.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,919.0 Cr | 1% | -2.3% | 6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,072.6 Cr | 2.4% | -1.1% | 53.4% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | 6.5% |
2.1% |
-21.1% |
SENSEX | 0.2% |
-0.2% |
21.6% |
You may also like the below Video Courses